• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Malaysia set to become Hepatitis C treatment hub of Asia

    BIOSPECTRUMASIA

    Ascletis` All-oral HCV Treatment Approved for Marketing in China

    PRNEWSWIRE

    WHO HCV Guidelines recommends Ascletis` Ravidasvir

    BIOSPECTRUM

    Ascletis` NDA for Its All-oral HCV Treatment Accepted by CFDA

    PR NEWSWIRE

    Making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO

    ENDPTS

    Epclusa`s fast-tracked Chinese approval might be late for Gilead

    FIERCE PHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.